Preparation andIn vitro release characteristics of hydrophilic albumin microspheres containing methotrexate and methotrexate-human serum albumin conjugates
- 23 Downloads
Release characteristics of five different types of hydrophilic albumin microspheres (HAM) containing different ratios of methotrexate-albumin (MTX-HSA) conjugates to free MTX; 1∶0 (HAMC), 3∶1 (HAMC3F), 1∶1 (HAMCF), 1∶3 (HAMCF3) and 0∶1 (HAMF) were investigated in the absence or presence of protease using dissolution tester. In all the HAMs studied except HAMC, the MTX was released bi-exponentially in the absence of protease; an initial fast release period up to approximately 6 h, and thereafter the release rate was very much slower. The fast release of MTX from the HAMs (such as HAMC3F, HAMCF, HAMCF3 and HAMF) at the initial phase is probably due to the release of “physically associated” MTX on the surface and/or entrapped in the near inner surface of HAMs and the slow release at the second phase is due to the release of entrapped free MTX from the core of the HAMs. The initial rate constants were 7.2, 8.7, 8.5 and 5.9 times greater than the second rate constants for HAMF, HAMCF3, HAMCF and HAMC3F, respectively. MTX release from HAMC was very slow and mono-phasic. It was at most 2.2% of the total entrapped amount by 24 h. The protease accelerated the release of MTX from the HAMs. The percentages of MTX released from HAMs up to 24 h were 100, 89.0, 75.0, 66.0 and 61.0% for HAMF, HAMCF3, HAMCF, HAMC3F and HAMC, respectively in the presence of protease and the corresponding values in the absence of protease were 30.2, 19.0, 10.0, 6.5 and 2.2%, respectively.In vitro release of MTX in the presence of protease varied according to the ratios of MTX-HSA conjugates to MTX; the data set from HAMF, HAMCF3 and HAMCF fits better to monophasic first-order profile more adequately than to zero-order profile, that of HAMC3 F to mono-phasic zero-order, and that of HAMC to bi-phasic zero-order. Above results suggested that zero-order release rate can be achieved by adjusting the ratio of MTX-HSA conjugates to MTX in the preparation of HAMs such as HAMC3F.
KeywordsHydrophilic albumin microspheres methotrexate methotrexate-human serum albumin conjugates in vitro drug release drug release by protease zero-order release
Unable to display preview. Download preview PDF.
- 2.Yang, J.-S.:Development of liver-targeting adriamycin delivery system using human serum albumin microspheres, Ph.D Thesis, Seoul National University, Seoul, Korea (1986).Google Scholar
- 3.Willmot, N., Chen, Y., Goldberg, J., Mcardle, C. and Florence, A. T.: Biodegradation rate of embolized protein microspheres in lung, liver and kidney of rats.J. Pharm. Pharmcol.,41, 433–438 (1989).Google Scholar
- 6.Kim, C.-K., Hwang, S.-J. and Yang, J.-S.: Development of specific organ-targeting drug delivery system. III.In vitro study on liver-targeting adriamycin delivery system using human serum albumin microspheres.J. Kor. Pharm. Sci. 19, 195–202 (1989).Google Scholar
- 18.Sheu, M. T., Moustafa, M. A. and Sokoloski, T. D.: Entrapment of bioactive compounds within native albumin beads. II. Effects of rate and extent of cross-linking on microbeads properties.J. Parent. Sci. Technol.,40, 253–258 (1986).Google Scholar